What do systematic reviews say?

75 questions · 75 findings · 34 reviews · Hepato-Biliary

Sort:Best matchNewest Highest certainty Download CSV

No studies found 75 · 100%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Microwave coagulation vs conventional surgery

Health‐related quality of life · people with liver metastases

The review found no eligible studies for this question.

1 finding from 1 review

Microwave coagulation for liver metastases 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Microwave coagulation vs radiofrequency ablation

Health‐related quality of life · people with liver metastases

The review found no eligible studies for this question.

1 finding from 1 review

Microwave coagulation for liver metastases 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Microwave coagulation in addition to conventional transarterial chemoembolisation vs chemoembolisation

Health‐related quality of life · people with liver metastases

The review found no eligible studies for this question.

1 finding from 1 review

Microwave coagulation for liver metastases 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Transjugular intrahepatic portosystemic shunts vs Conventional treatment

Health‐related quality of life · adults with hepatorenal syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Transjugular intrahepatic portosystemic shunts for adults with hepatorenal syndrome 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Health‐related quality of life · participants with gallstone disease (cholesterol, pigment, or mixed)

The review found no eligible studies for this question.

1 finding from 1 review

Modified dietary fat intake for treatment of gallstone disease in people of any age 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Double‐dose adenovirus‐thymidine kinase with ganciclovir (ADV‐TK/GCV) plus liver transplantation vs liver transplantation

Health‐related quality of life · participants with unresectable hepatocellular carcinoma

The review found no eligible studies for this question.

1 finding from 1 review

Gene therapy for people with hepatocellular carcinoma 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Recombinant human adenovirus‐p53 and hydroxycamptothecin (rAd‐p53/HCT) vs hydroxycamptothecin

Health‐related quality of life · participants with unresectable hepatocellular carcinoma

The review found no eligible studies for this question.

1 finding from 1 review

Gene therapy for people with hepatocellular carcinoma 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Recombinant human adenovirus‐p53 and 5‐fluorouracil (rAd‐p53/5‐Fu) plus transarterial chemoembolisation vs chemoembolisation

Health‐related quality of life · participants with unresectable hepatocellular carcinoma

The review found no eligible studies for this question.

1 finding from 1 review

Gene therapy for people with hepatocellular carcinoma 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

E1B‐deleted (dl1520) adenovirus vs percutaneous alcohol injection

Health‐related quality of life · participants with unresectable hepatocellular carcinoma

The review found no eligible studies for this question.

1 finding from 1 review

Gene therapy for people with hepatocellular carcinoma 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Adenovirus‐thymidine kinase with ganciclovir (ADV‐TK/GCV) plus liver transplantation vs liver transplantation

Health‐related quality of life · participants with unresectable hepatocellular carcinoma

The review found no eligible studies for this question.

1 finding from 1 review

Gene therapy for people with hepatocellular carcinoma 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Prostaglandin vs placebo or usual care

Health‐related quality of life · adult patients after liver transplantation.

The review found no eligible studies for this question.

1 finding from 1 review

Prostaglandins for adult liver transplanted recipients 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Band ligation vs no intervention or a sham procedure

Health‐related quality of life · children with portal hypertension and large oesophageal varices, without previous gastrointestinal bleeding or beta‐blocker treatment

The review found no eligible studies for this question.

1 finding from 1 review

Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and… 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Adjuvant chemotherapy vs no chemotherapy

Health‐related quality of life · people with resectable cholangiocarcinoma

The review found no eligible studies for this question.

1 finding from 1 review

Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Distal splenorenal shunt vs endoscopic intervention

Health‐related quality of life · participants with cirrhosis and with previous oesophagogastric variceal bleeding

The review found no eligible studies for this question.

1 finding from 1 review

Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in… 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Transjugular intrahepatic portosystemic shunts vs endoscopic intervention with or without medical treatment

Health‐related quality of life · participants with cirrhosis and with previous oesophagogastric variceal bleeding

The review found no eligible studies for this question.

1 finding from 1 review

Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in… 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Portosystemic shunts vs endoscopic intervention with or without medical treatment

Health‐related quality of life · participants with cirrhosis and with previous oesophagogastric variceal bleeding

The review found no eligible studies for this question.

1 finding from 1 review

Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in… 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Total shunt vs endoscopic intervention

Health‐related quality of life · participants with cirrhosis and with previous oesophagogastric variceal bleeding

The review found no eligible studies for this question.

1 finding from 1 review

Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in… 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Percutaneous ethanol injection vs no intervention, other ablation methods, or systemic treatment

Health‐related quality of life · people with liver metastases

The review found no eligible studies for this question.

1 finding from 1 review

Percutaneous ethanol injection for liver metastases 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Transarterial embolisation vs no intervention

Health‐related quality of life · people with liver metastases

The review found no eligible studies for this question.

1 finding from 1 review

Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Transarterial chemoembolisation vs no intervention

Health‐related quality of life · people with liver metastases

The review found no eligible studies for this question.

1 finding from 1 review

Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found